Skip to main content
OpenTrials
Completed

NCT Number: NCT00298207

Walking Intervention in African American Adults With Newly Diagnosed Hypertension

High blood pressure (hypertension) is one the most common and serious chronic diseases among Americans, especially among the African Americans. The purpose of this study is to explore the effect six month long walking intervention on blood pressure in adult African American with a newly diagnosed high blood pressure (hypertension). The hypothesis is that the group with encouragement to walk extra 30 minutes a day for 5-7 days a week may lower their blood pressure compared to the control group without the encouragement.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–59 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Family Medicine, College of Medicine, University of Illinois at Chicago

Chicago, Illinois, 60612, United States

About this study

Hypertension is a very common and serious chronic disease, which affects approximately 50 million people in the United States. Defined by systolic blood pressure (SBP) of 140 mm Hg or higher or diastolic blood pressure (DBP) of 90 mm Hg or higher, hypertension increases the risk for adverse cardiovascular and renal outcomes, such as myocardial infarction, stroke, congestive heart failure, end-stage renal disease, and peripheral vascular disease. Data from as early as the 1960's indicates that the disease disproportionately effects subgroups of the population, with non-Hispanic African Americans having an age-adjusted prevalence of hypertension (32.4%) almost 40% higher than that noted in non-Hispanic whites (23.3%) and Mexican Americans (22.6%). Although hypertension-related mortality seems to be declining among African Americans, it continues to be a problem which disproportionately affects African Americans more than Whites, particularly in younger age groups.

The management of hypertension is of particular importance for primary care providers, due not only to its prevalence but also because it is a modifiable risk factor for cardiovascular diseases. Although, there are a number of medications available for lowering blood pressure, the first step in managing hypertension should be life-style modification, including weight reduction, increased physical activity, and restriction of dietary sodium and alcohol intake.

Walking seems to be one of the safest and simplest exercises for hypertensive patients of all age groups. Combinations of walking, jogging and bicycling have been shown to be effective in managing hypertension, but there are inherent risks associated with strenuous exercises like jogging and bicycling. Additionally, as most hypertensive patients tend to be overweight, jogging may not be an easy exercise for them. The positive effect of brisk walking on hypertension has been demonstrated in postmenopausal women. Despite the recognized importance of finding ways to effectively manage hypertension in African Americans, there is a paucity of studies on the impact of walking in this population. The purpose of this research was to study the impact of walking an extra 30 minutes a day on blood pressure in 25 to 59 year old African Americans with newly diagnosed hypertension.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • African American male
  • newly diagnosed hypertension
  • between age 25 to 59

Exclusion criteria

  • Not being able to walk unassisted,
  • not having telephone access,
  • being involved in regular sports activity,
  • taking any type of antihypertensive medications,
  • advanced renal, cardiovascular, or obstructive pulmonary disease.

Treatment and study plan

Walking (behavior)

Behavioral

Primary outcomes

  1. Change in Systolic and diastolic blood pressure over duration of study

    Time frame: Blood Pressure will be measured at study entry, at three months and at six months

Sponsors and collaborators

Lead sponsor

University of Illinois at Chicago

Other

Registry information

Important dates

Study start
2001
Study completion
2004
First posted
Mar 1, 2006
Registry last updated
Mar 13, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.